WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Stock Ownership - Who owns Tenax Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tenax Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher Thomas GiordanoCEO2026-07-13219$3.55
$777.23Buy
Christopher Thomas GiordanoCEO2026-07-138,500$5.94
$50.49kBuy
Stuart RichChief Medical Officer2025-12-092,500$10.22
$25.54kBuy
Stuart RichChief Medical Officer2025-12-082,500$10.10
$25.25kBuy
Stuart RichChief Medical Officer2025-12-042,500$9.20
$23.00kBuy
Stuart RichChief Medical Officer2025-12-031,500$9.08
$13.62kBuy
Stuart RichChief Medical Officer2025-12-021,000$9.01
$9.01kBuy
Christopher Thomas GiordanoCEO2025-11-20538$7.59
$4.08kBuy
Christopher Thomas GiordanoCEO2025-11-19455$7.51
$3.42kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy

1 of 2

TENX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TENX insiders and whales buy or sell their stock.

TENX Shareholders

What type of owners hold Tenax Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC16.11%6,027,985$10.37MInsider
Price T Rowe Associates Inc7.89%2,951,116$5.08MInstitution
Janus Henderson Group PLC4.85%1,815,474$3.12MInstitution
Venrock Adviser LLC4.48%1,675,262$2.88MInstitution
Perceptive Advisors LLC3.87%1,447,782$2.49MInstitution
John P. Kelley3.43%1,282,932$2.21MInsider
Ikarian Capital LLC2.72%1,017,600$1.75MInstitution
Stonepine Capital Management LLC2.61%975,200$1.68MInstitution
Logos Global Management LP1.67%625,000$1.08MInstitution
Morgan Stanley1.59%596,564$1.03MInstitution

1 of 3

TENX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TENX57.43%21.42%Net BuyingNet Buying
CYPH6.88%48.16%Net Selling
IBIO35.96%64.04%Net Buying
RNTX13.32%42.00%Net BuyingNet Buying
PLRX65.47%34.53%Net Selling
View Top Biotech Stocks

Tenax Therapeutics Stock Ownership FAQ

Who owns Tenax Therapeutics?

Tenax Therapeutics (NASDAQ: TENX) is owned by 57.43% institutional shareholders, 21.42% Tenax Therapeutics insiders, and 21.15% retail investors. Armistice Capital LLC is the largest individual Tenax Therapeutics shareholder, owning 6.03M shares representing 16.11% of the company. Armistice Capital LLC's Tenax Therapeutics shares are currently valued at $11.03M.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.